- ►diabetesjournals.org J Pearson, R Bergenstal - Diabetes Spectrum, 2001 - Am Diabetes Assoc Randomized clinical trials have definitively shown that achieving
near-normoglycemia reduces the risk of diabetes complications in individuals
with either type 1 or type 2 diabetes. The Diabetes Control and ... Cited by 9 - Related articles - All 2 versions
J Unger - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Diabetes self-management is not always the simplest of tasks. Patients with
diabetes do not have a functioning pancreas. They rely on their knowledge to
guide them through the complex decisions that must be made continually. ... Related articles - All 3 versions
DA Streja - Primary Care Diabetes, 2008 - Elsevier It is well documented that tight glucose control prevents the microvascular
complications of diabetes, and many studies suggest that postprandial
hyperglycemia may be associated with macrovascular complications. ... Related articles - All 8 versions
J Kesavadev, S Balakrishnan, S Ahammed, S … - Diabetes Technology & Therapeutics, 2009 - liebertonline.com Abstract Background: The standard treatment regimen for insulin-dependent type 2
diabetes is multiple daily injections (MDI) of insulin, but continuous
subcutaneous insulin infusion (CSII) with an insulin pump offers more ... Related articles - All 3 versions
- ►insulinjournal.com [PDF] L Kiblinger, NL Braza - Insulin, 2007 - Elsevier Methods: Review of the literature from 2003 to 2006 was undertaken using the
search terms diabetes education, efficacy of lifestyle education, AIC reduction,
and certified diabetes educators. Landmark studies such as the Diabetes ... Related articles - All 2 versions
- ►ksu.edu.sa [PDF] MP Glucose - CLINICAL DIABETES, 2004 - Am Diabetes Assoc Over the past decade, a major interest in postprandial glucose (PPG) has
emerged, in part because of a plethora of new medica- tions that specifically
target PPG. These include insulin analogs (lispro and aspart), insulin ... Related articles - All 6 versions
IB Hirsch - Endocrine Practice, 2004 - AACE The development of self-monitoring of blood glucose (SMBG) in 1978 ushered in an
era of unprecedented ther- apeutic and technologic innovation in diabetes care
(1-4). Unlike urine testing, the primary method for identifying ... Cited by 21 - Related articles - BL Direct - All 2 versions
ZT Bloomgarden - Diabetes care, 2002 - Am Diabetes Assoc Brian Hoogwerf (Cleveland, OH) discussed the use of angiotensin-converting
enzyme inhibitors (ACEIs). Physiologically, the renal effect of the agents
appears to involve lowering of intrarenal pressures. Early studies showed ... Cited by 1 - Related articles - All 5 versions
